Literature DB >> 2508477

Glaucoma in the Maroteaux-Lamy syndrome.

L B Cantor1, J A Disseler, F M Wilson.   

Abstract

We report four patients who had glaucoma in association with the Maroteaux-Lamy syndrome. Two of these patients had acute angle-closure glaucoma, one had chronic angle-closure glaucoma, and one was treated for open-angle glaucoma; however, the angle structures could not be seen by gonioscopy. Standard peripheral iridectomy was inadequate for treatment of this angle-closure glaucoma because of the considerably increased thickness of the peripheral cornea that occurs in these patients. Our findings suggest that glaucoma may be more common in the Maroteaux-Lamy syndrome than has been realized and that the initial mechanism is secondary acute or chronic angle closure not related to pupillary block.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508477     DOI: 10.1016/s0002-9394(14)73311-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

Review 1.  The role of proteolytic cellular systems in trabecular meshwork homeostasis.

Authors:  Paloma B Liton; Pedro Gonzalez; David L Epstein
Journal:  Exp Eye Res       Date:  2008-11-12       Impact factor: 3.467

2.  Cultured porcine trabecular meshwork cells display altered lysosomal function when subjected to chronic oxidative stress.

Authors:  Paloma B Liton; Yizhi Lin; Coralia Luna; Guorong Li; Pedro Gonzalez; David L Epstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-09       Impact factor: 4.799

3.  Atypical Presentation of Acute Angle-Closure Glaucoma in Maroteaux-Lamy Mucopolysaccharidosis with Patent Prophylactic Laser Peripheral Iridotomy: A Case Report.

Authors:  Malini Veerappan; Garrick Chak; Christine Shieh; Pratap Challa
Journal:  Perm J       Date:  2017

4.  Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis?

Authors:  Susanne Pitz; Olufunmilola Ogun; Laila Arash; Elke Miebach; Michael Beck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-22       Impact factor: 3.117

5.  Potential role of lysosomal dysfunction in the pathogenesis of primary open angle glaucoma.

Authors:  Paloma B Liton; Yizhi Lin; Pedro Gonzalez; David L Epstein
Journal:  Autophagy       Date:  2009-01-31       Impact factor: 16.016

6.  Visual Dysfunction of Type I and VI Mucopolysaccharidosis Patients Evaluated with Visual Evoked Cortical Potential.

Authors:  Bruno Duarte Gomes; Givago da Silva Souza; Gustavo Monteiro Viana; Isabel Cristina Neves de Souza; Patricia do Socorro Queiroz Feio; Ida Vanessa Doederlein Schwartz; Diane Ruschel Marinho; Manoel da Silva Filho; Roberto Giugliani; Luiz Carlos de Lima Silveira; Luiz Carlos Santana da Silva
Journal:  Case Rep Ophthalmol       Date:  2012-03-26

Review 7.  Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA.

Authors:  Christian J Hendriksz; Maisoon Al-Jawad; Kenneth I Berger; Sara M Hawley; Rebecca Lawrence; Ciarán Mc Ardle; C Gail Summers; Elizabeth Wright; Elizabeth Braunlin
Journal:  J Inherit Metab Dis       Date:  2012-02-23       Impact factor: 4.982

8.  Comparison of Rebound Tonometry, Perkins Applanation Tonometry and Ocular Response Analyser in Mucopolysaccharidosis Patients.

Authors:  Joanna Wasielica-Poslednik; Christina Butsch; Christina Lampe; Heike Elflein; Julia Lamparter; Veronika Weyer; Susanne Pitz
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

9.  Influence of Corneal Opacity on Intraocular Pressure Assessment in Patients with Lysosomal Storage Diseases.

Authors:  Joanna Wasielica-Poslednik; Giuseppe Politino; Irene Schmidtmann; Katrin Lorenz; Katharina Bell; Norbert Pfeiffer; Susanne Pitz
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 10.  Glaucoma in mucopolysaccharidoses.

Authors:  Weijing Kong; Jing Zhang; Cheng Lu; Yingxue Ding; Yan Meng
Journal:  Orphanet J Rare Dis       Date:  2021-07-15       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.